Cancer Keys: COVID-19 and Neutropenic Sepsis

3rd April 2020

Neutropenic sepsis is a potentially fatal complication of anticancer treatment (particularly chemotherapy).

Helpful hint:

NICE have produced a COVID-19 rapid guideline on the delivery of systemic anticancer treatments. If patients present with COVID-19 symptoms this guidance recommends:

  • Be aware that patients having systemic anticancer treatments are immunocompromised and may have atypical presentations of COVID‑19. Also, symptoms of COVID‑19, neutropenic sepsis and pneumonitis may be difficult to differentiate at initial presentation.
  • Advise all patients to contact their local cancer chemotherapy helpline (rather than NHS 111) if they feel unwell to ensure their symptoms are appropriately assessed.
  • If patients have fever (with or without respiratory symptoms), suspect neutropenic sepsis because this can be rapid and life-threatening, and follow the NICE guideline on neutropenic sepsis, which recommends referring patients with suspected neutropenic sepsis immediately for assessment in secondary or tertiary care.

Cancer Keys are brought to you by GatewayC.

Download this Cancer Key here

LinkedIn Twitter | Facebook

Latest from the Blog

MGUS and Myeloma: What’s the link?

MGUS and Myeloma: What’s the link?

15th February 2019 MGUS is a benign condition which does not usually require treatment. However, a small number of patients diagnosed with MGUS will go on to develop myeloma. Understanding MGUS Monoclonal gammopathy of undetermined significance (MGUS) is a benign...

read more

Related Posts

MGUS and Myeloma: What’s the link?

MGUS and Myeloma: What’s the link?

15th February 2019 MGUS is a benign condition which does not usually require treatment. However, a small number of patients diagnosed with MGUS will go on to develop myeloma. Understanding MGUS Monoclonal gammopathy of undetermined significance (MGUS) is a benign...

read more